Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels.  He is the Director and Professor at the Utah Tech University Center for Precision Medicine and Functional Genomics and Medical Director for Precision Medicine at the Geriatric Oncology Consortium.  He is also a Precision Health Advisor across the 33 hospital, ~400 clinic, 9 state Intermountain HealthCare System.  Dr McLeod was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council.  Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy.  He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies.  Howard has published over 600 peer reviewed papers on precision medicine, pharmacogenomics, or clinical pharmacology and continues to work to advance innovative healthcare.